Target Details
| UniProt AC | P42345 |
|---|---|
| Gene Symbol | MTOR |
| Protein Name | Serine/threonine-protein kinase mTOR |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF02259 (FAT) PF02260 (FATC) PF08771 (FRB_dom) PF23593 (HEAT_ATR) PF11865 (mTOR_dom) PF00454 (PI3_PI4_kinase) |
Summary
- Multi-target molecules 2,517
- Clinical molecules 193
- Avg pChEMBL 7.75
KEGG Pathways (53)
- AMPK signaling pathway
- Acute myeloid leukemia
- Adipocytokine signaling pathway
- Alzheimer disease
- Amyotrophic lateral sclerosis
- Apelin signaling pathway
- Autophagy - animal
- Autophagy - other
- Breast cancer
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - receptor activation
- Choline metabolism in cancer
- Colorectal cancer
- Diabetic cardiomyopathy
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- ErbB signaling pathway
- Gastric cancer
- Glioma
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Huntington disease
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- Lysosome biogenesis
- MicroRNAs in cancer
- Neutrophil extracellular trap formation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Shigellosis
- Spinocerebellar ataxia
- Th17 cell differentiation
- Thermogenesis
- Thyroid hormone signaling pathway
- Type II diabetes mellitus
- mTOR signaling pathway
Associated Diseases (2)
Active Molecules (2,517)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
MQGQMVPIFSWNPW
|
8.7 | IC50 | 2 | — | |
NECBLBSHQGQKDS
|
8.7 | IC50 | 2 | — | |
NFGMKGKKDCYXPD
|
8.7 | IC50 | 2 | — | |
NHJAMHLWORQRFH
|
8.7 | IC50 | 3 | — | |
NLKBXYZEDAMSSX
|
8.7 | IC50 | 2 | — | |
OSBPEHXKXSVZIB
|
8.7 | IC50 | 2 | — | |
RUSWLTDNJLODMQ
|
8.7 | Ki | 2 | — | |
SWPWEUQKSNRYSG
|
8.7 | IC50 | 2 | — | |
TTWYGQNNRZQORN
|
8.7 | IC50 | 2 | — | |
TXYMOTSBKCCEGY
|
8.7 | IC50 | 2 | — | |
TZFPAPDORLMPQE
|
8.7 | IC50 | 2 | — | |
UHDNTCSWNAXDIA
|
8.7 | IC50 | 2 | — | |
UJUYOMFQDNYFOT
|
8.7 | IC50 | 2 | — | |
VLGFLFLDANVHKG
|
8.7 | IC50 | 2 | — | |
VLUBDPDZETYNRC
|
8.7 | IC50 | 2 | — | |
WARHZMCNVITGFR
|
8.7 | IC50 | 2 | — | |
WEJJSFQXOHGWBL
|
8.7 | IC50 | 2 | — | |
WNXLWTJPPPCZQB
|
8.7 | IC50 | 2 | — | |
WRWNEQAYJQFZBU
|
8.7 | IC50 | 2 | — | |
XODHFMOZHXRSNF
|
8.7 | IC50 | 2 | — | |
YGBMCLDVRUGXOV
|
8.7 | pIC50 | 8 | Yes | |
ZAXFYGBKZSQBIV
|
8.7 | IC50 | 5 | — | |
ZDWBVUMFWKTFRY
|
8.7 | IC50 | 2 | — | |
GYRKINABGRSUGW
|
8.7 | Ki | 2 | — | |
RVHGXIUOUJYWPJ
|
8.7 | IC50 | 5 | — | |
DUVPEHGLMDEEMV
|
8.7 | IC50 | 4 | — | |
FJEZIFXPFQZBFH
|
8.7 | pIC50 | 2 | Yes | |
GPYZSWHMVWHHIR
|
8.7 | pIC50 | 2 | Yes | |
IBSJBEZUWZZXIZ
|
8.7 | IC50 | 2 | — | |
KBBFVOAXWPUPGK
|
8.7 | IC50 | 2 | — | |
MLVGNMUJLBIZJL
|
8.7 | IC50 | 2 | — | |
MXLZNYSXMWKNRW
|
8.7 | Ki | 2 | — | |
NNYPLMSOAFZNTE
|
8.7 | IC50 | 3 | — | |
OSJMQBRYMOIUEH
|
8.7 | IC50 | 2 | — | |
RGEBDUAFRMIURN
|
8.7 | pIC50 | 2 | Yes | |
VQRJMTKYCCPCRG
|
8.7 | IC50 | 2 | — | |
WZDLLWUKMJOVAK
|
8.7 | IC50 | 5 | — | |
ZPTXTOBTOXKPKB
|
8.7 | IC50 | 2 | — | |
DIJVXTHTUCMDST
|
8.7 | IC50 | 2 | — | |
JFXLBGOSVVDUOC
|
8.7 | Ki | 2 | — | |
KJWISZTXRAFJRG
|
8.7 | IC50 | 2 | — | |
UUPJZLUFXXSBMO
|
8.7 | IC50 | 2 | — | |
AYKQWTUMCIMOFO
|
8.7 | IC50 | 2 | — | |
FUDRVRQHDVLJRT
|
8.7 | IC50 | 3 | — | |
FWRJSVJUWJBVFB
|
8.7 | Ki | 2 | — | |
JGRISWOXHZGZPV
|
8.7 | Ki | 5 | — | |
LILBAKYEAUUWIF
|
8.7 | IC50 | 5 | — | |
MNFLAXUMRDDWAF
|
8.7 | IC50 | 2 | — | |
RBFZKUBWJMBTHB
|
8.7 | IC50 | 5 | — | |
WHAYNIDTNNWHOG
|
8.7 | IC50 | 2 | — |